Here are 1-2 analogies to describe P3 Health Partners (PIII):

• Like One Medical (acquired by Amazon) specifically tailored for seniors, emphasizing comprehensive and preventative primary care.
• A primary care network for seniors, similar to the clinic side of Kaiser Permanente, but focused on managing their health outcomes proactively.

• Primary Health Care Services: Provides comprehensive medical care for common illnesses and preventive health maintenance.
• Clinical Operations Services: Manages and optimizes the day-to-day functions of healthcare facilities and practices.
• Population Health Management Services: Develops strategies and programs to improve health outcomes and reduce healthcare costs for specific patient populations.
• Senior Wellness Centers: Operates dedicated centers offering health and wellness programs specifically tailored for senior citizens.

P3 Health Partners (PIII) primarily sells its integrated healthcare services, including clinical operations, population health management, and direct primary care, to health insurance companies. These insurance companies contract with P3 to manage the health and care of their members, particularly those enrolled in Medicare Advantage plans. Therefore, its major customers are leading health insurance providers:

• UnitedHealth Group (NYSE: UNH)
• Humana Inc. (NYSE: HUM)
• Elevance Health, Inc. (NYSE: ELV) (formerly Anthem)
• CVS Health Corporation (NYSE: CVS) (operates Aetna)
• Centene Corporation (NYSE: CNC)

Dr. Aric Coffman, Chief Executive Officer

Dr. Aric Coffman was appointed Chief Executive Officer of P3 Health Partners on May 8, 2024. He has over two decades of experience leading provider organizations in value-based care. Prior to P3, Dr. Coffman served as CEO of Honest Medical Group, a startup that grew to serve over 120,000 Medicare lives and was a Rubicon Founders portfolio company. He also held leadership positions at The Everett Clinic and Northwest Physicians Network, part of OptumCare, where he doubled Medicare Advantage membership and expanded into full-risk market segments. His career also includes roles as Chairman of Surgery, Chief Medical Officer, and President of DaVita Medical Group New Mexico, and he was involved during the Optum acquisition of DaVita Medical Group.

Leif Pedersen, Chief Financial Officer

Leif Pedersen will assume the role of Chief Financial Officer for P3 Health Partners effective October 1, 2024, succeeding Atul Kavthekar. He brings more than 25 years of experience in finance, accounting, and operations within large-scale, publicly traded organizations, including 9 years in value-based care and 6 years of "Big Four" public accounting. Most recently, Pedersen served as Vice President of Finance & CFO Shared Services for Optum Health, a division of UnitedHealth Group. Before Optum Health, he was Vice President of Finance & CFO IT at DaVita Medical Group, where he led the financial separation of DaVita's IT organization from its parent enterprise. He began his career as a Senior Assurance Manager at Arthur Andersen/KPMG.

Amir Bacchus, MD, MBA, Chief Medical Officer & Co-Founder

Dr. Amir Bacchus is a co-founder of P3 Health Partners and serves as its Chief Medical Officer. With 23 years of experience, he has operated, managed, and guided physician groups, focusing on healthcare delivery and promoting improved quality, access, and cost of care. Prior to co-founding P3, Dr. Bacchus was the Chief Medical Officer and Co-Founder of HealthCare Partners (HCP) Desert Region, as well as the company's National Corporate Medical Director. He also recently served as Chief Medical Officer for Ascension Medical Group through a consulting agreement with P3.

William Bettermann, Executive Vice President and Chief Operating Officer

William Bettermann is the Executive Vice President and Chief Operating Officer of P3 Health Partners. He has nearly 25 years of healthcare leadership experience with a strong track record of success in the value-based care arena.

Todd M. Smith, Chief Legal and Compliance Officer

Todd M. Smith serves as the Chief Legal and Compliance Officer for P3 Health Partners.

Key Risks to P3 Health Partners (PIII)

P3 Health Partners faces significant business risks, primarily centered on its financial viability, the complex regulatory environment of the healthcare sector, and its ability to effectively manage membership and medical costs.

The most pressing risk to P3 Health Partners is its **financial health and the substantial doubt about its ability to continue as a going concern**. The company has a consistent history of net losses and anticipates continued losses in the foreseeable future. Financial reports indicate substantial net losses for full year 2024 and the first quarter of 2025, coupled with a significant cash burn rate. The company's financial strength is rated poorly, marked by considerable debt levels, and its liquidity is concerning, as evidenced by low current and quick ratios and a high debt-to-equity ratio. Furthermore, its Altman Z-Score places it within the "distress zone," signaling a potential risk of bankruptcy. There is also a risk that the company may not comply with its debt covenants in the future.

A second significant risk stems from the **regulatory landscape and intense market competition within the healthcare industry**. The sector in which P3 Health Partners operates is highly competitive, demanding continuous adaptation to maintain market share. The company is subject to stringent government regulations, and evolving healthcare policies present a constant challenge to its operations. Being heavily reliant on federal government healthcare programs, P3 Health Partners is vulnerable to changes in policies or reimbursement rates, which could materially impact its financial performance. The value-based care market, a core focus for P3, is also becoming increasingly saturated with numerous competitors.

Finally, **membership and cost management** pose a key operational risk to P3 Health Partners. The company faces ongoing challenges from elevated medical utilization costs, particularly concerning Part B services and increased unit costs, which require continuous attention to improve financial performance. P3 has experienced decreases in its at-risk membership due to strategic rationalization of its network and payer relationships. Attracting and retaining both new members and physician partners is an ongoing critical hurdle for the company.

The rapid expansion and acquisition strategies of well-capitalized retail and technology giants (e.g., Amazon, CVS, Walgreens) into primary care, particularly focused on value-based care models and senior health. These entrants are leveraging significant capital, technological expertise, and existing customer bases to build integrated, tech-enabled primary care networks and population health management capabilities (e.g., Amazon's acquisition of One Medical, CVS's acquisition of Oak Street Health, Walgreens' partnership with VillageMD), which directly compete with and aim to disrupt traditional primary health care providers and senior wellness centers like P3 Health Partners by offering new models of convenient, data-driven, and often more cost-effective care.

• Growth in Medicare Advantage (MA) Membership: P3 Health Partners anticipates increasing its Medicare Advantage membership. For instance, the company provided full-year 2024 guidance projecting Medicare Advantage members to be between 125,000 and 135,000. Furthermore, there is an expectation of adding an additional 25,000 Medicare Advantage lives to the pipeline for 2026.
• Expansion to New Markets and Strategic Partnerships/Joint Ventures: The company plans to grow through strategic collaborations and entering new geographical areas. P3 Health Partners has a robust pipeline of strategic partnerships aimed at driving growth. An example is the joint venture with Commonwealth Primary Care ACO, which expands value-based care services across multiple states, including an increased footprint in Maricopa County, Arizona. This strategic joint venture is expected to add approximately 13,000 ACO members.
• Improved Medical Cost Management and Operational Efficiencies: P3 Health Partners is focused on enhancing its operational effectiveness and managing medical costs more efficiently. The company has identified a $120 million to $170 million EBITDA expansion opportunity for 2026 through operational gains. Management has highlighted that operational improvement plans are embedded in the business, leading to over $100 million in EBITDA improvement year-over-year. This includes rationalizing their provider network to improve margin performance by exiting groups that do not align clinically or economically and growing where their Care Enablement Model delivers strong outcomes.
• Premium Rate Improvements: The company expects to benefit from improvements in premium rates. Management has indicated expectations for a 5% base rate improvement in premiums across its four markets for 2026, with further guidance on coding improvement impacts to be provided.

Share Issuance

• P3 Health Partners completed a 1-for-50 reverse stock split, effective April 11, 2025. This action was taken to consolidate shares and increase the per-share trading price to maintain compliance with Nasdaq's minimum bid price requirement.
• In May 2024, the company completed a private placement, raising $39.8 million net of offering costs.
• P3 Health Partners has engaged in multiple financing transactions with VBC Growth SPV entities, issuing promissory notes to raise capital.

Inbound Investments

• The company is in discussions with its largest shareholder for a proposed financing transaction in February 2025, involving an additional $30 million unsecured promissory note and warrants. This transaction is expected to be similar to a financing transaction completed in December 2024.
• P3 Health Partners secured a $25 million financing deal to support its working capital needs, as reported in a previous 8-K filing.

Capital Expenditures

• P3 Health Partners is focused on leveraging its existing infrastructure to achieve operating efficiencies.
• The company is making technology investments and focusing on operational efficiencies to create measurable cost savings, margin expansion, and enhanced revenue opportunities.